Nektar Therapeutics Sees Something In The Data And Puts Its Drug To The Test Seeking Alpha Nektar Therapeutics Sees Something In The Data And Puts Its Drug To The Test. Nektar (NKTR) 5 months
Nektar Therapeutics Likely To Drift And Wobble Ahead Of Key Phase II Data In 2025 Seeking Alpha 3 months